NCT01466387 - A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults | Biotech Hunter

Enrollment

552

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Meningococcal DiseaseMeningococcal MeningitisTyphoidYellow FeverRabiesJapanese Encephalitis

Interventions

BIOLOGICAL

Typhoid Vi Polysaccharide Vaccine

One dose of typhoid Vi polysaccharide vaccine.

BIOLOGICAL

Yellow Fever Vaccine

One dose of yellow fever vaccine.

BIOLOGICAL

Japanese Encephalitis Vaccine

Two doses of Japanese Encephalitis Vaccine.

BIOLOGICAL

Rabies Vaccine

Three doses of Rabies vaccine.

BIOLOGICAL

MenACWY-CRM Vaccine

One dose of MenACWY-CRM vaccine.

Trial Locations (5)

Berliner Centrum Fur Reise und Tropenmedizin, Jaegerstrasse 67-69

Universitat Rostock, Ernst Heydemann Str 6, Rostock

Bernhard Nocht Strasse 74

University of Munich Georgenstr.5, München

Centrum ockovani a cestovni mediciny (Vaccination and Travel Medicine Centre) Poliklinika II, Bratri Stefanu 895